- Recent article finds that data remains one of main drivers of medical research in 2021.
- New technologies employing AI powered by big data provide new solutions for tackling health problems, expand possibilities of clinical research
- RYAH combines power of devices combined with data to impact future of medical research to advance treatment of various medical conditions
A recent Becker’s Hospital Review article cites 10 emerging trends in health IT that will shape this field in 2021, reporting that big data management is becoming a need as the use of artificial intelligence (“AI”) and machine learning in healthcare continues to blossom (https://ibn.fm/bMPIY). With the increasing demand in the medical space for application of analytics powered by novel technology, RYAH Group is set to benefit as a leading digital health care analytics and technology company committed to advancing the world’s transition to remote-health solutions and data analytics in patient treatments.
With the digitalization of medical records and improved medical analytics coupled with a proliferation of wearables, there has been an explosion of medical data over the past decade. That explosion has led to a revolution in medical and health-care research. The vast amount of data available for analysis enables AI-powered algorithms to transform the medical field more than…
NOTE TO INVESTORS: The latest news and updates relating to RYAH Group are available in the company’s newsroom at https://ibn.fm/RYAH
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
[email protected]
BioMedWire is part of the InvestorBrandNetwork.